13D Filing: Scopia Capital Reveals Big Stake in Conmed Corp (CNMD)

Published on February 23, 2016 at 5:52 pm by Meena Krishnamsetty in Hedge Funds,News

Page 1 of 23

Activist shareholders continue to be closely-monitored and imitated by investors, given their ability to affect positive change at companies. Whether it be by pressuring companies to set loose underperforming divisions, pushing for change on the company’s Board, or advocating for more of the company’s profits to be distributed to shareholders in the form of share buybacks and/or dividend payments, activist investors know how to move the needle in the right direction. Embedded below and on the following pages is the latest 13D activist filing issued by Matt Sirovich and Jeremy Mindich‘s Scopia Capital, in relation to its position in CONMED Corporation (NASDAQ:CNMD). The filing reveals a new position of 1.69 million shares held by the investment firm, giving them ownership of 6.1% of the issuer’s common stock. The filing does not reveal what plans, if any, Scopia Capital may have in mind regarding its investment.

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name	Sole Voting Power	Shared Voting Power	Sole Dispositive Power	Shared Dispositive Power	Aggregate Amount Owned Power	Percent of Class
SCOPIA PX	434,231	1,693,356	434,231	1,693,356	434,231	1.6%
SCOPIA PARTNERS	12,261	1,693,356	12,261	1,693,356	12,261	Less than 1%
SCOPIA HEALTH CARE	33,666		33,666		33,666	Less than 1%
SCOPIA WINDMILL FUND	309,512		309,512		309,512	1.1%
SCOPIA INTERNATIONAL MASTER FUND	77,391		77,391		77,391	Less than 1%
SCOPIA PX INTERNATIONAL MASTER FUND	558,629		558,629		558,629	2.0%
SCOPIA HEALTH CARE INTERNATIONAL MASTER FUND	245,043		245,043		245,043	Less than 1%
SCOPIA CAPITAL GP	1,670,733		1,670,733		1,670,733	6.0%
SCOPIA CAPITAL MANAGEMENT	1,693,356		1,693,356		1,693,356	6.1%
SCOPIA MANAGEMENT, INC	1,693,356		1,693,356		1,693,356	6.1%
MATTHEW SIROVICH					1,693,356	6.1%
JEREMY MINDICH					1,693,356	6.1%

Matt Sirovich And Jeremy Mindich

Scopia Capital

We may use your email to send marketing emails about our services. Click here to read our privacy policy.

Page 1 of 23 SEC Filing

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

(Rule 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

§ 240.13d-2(a)

(Amendment No. 1)1

CONMED Corporation

(Name of Issuer)

Common Stock, $0.01 par value

(Title of Class of Securities)

207410101

(CUSIP Number)

SAMANTHA NASELLO

SCOPIA CAPITAL MANAGEMENT LP

152 West 57th Street, 33rd Floor

New York, New York 10019

(212) 370-0303

STEVE WOLOSKY

OLSHAN FROME WOLOSKY LLP

Park Avenue Tower

65 East 55th Street

New York, New York 10022

(212) 451-2300

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

February 19, 2016

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ¨.

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7 for other parties to whom copies are to be sent.

_______________

1 The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Follow Conmed Corp (NASDAQ:CNMD)Follow Conmed Corp (NASDAQ:CNMD)

We may use your email to send marketing emails about our services. Click here to read our privacy policy.

Page 1 of 23

Next >>

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.

We may use your email to send marketing emails about our services. Click here to read our privacy policy.